Robotic versus open simple prostatectomy for benign prostatic hyperplasia in large glands: single-centre study.

Area of Science:

• Urology
• Minimally Invasive Surgery
• Surgical Technology

Background:

• Benign prostatic hyperplasia (BPH) is a common condition requiring surgical intervention.
• Open simple prostatectomy (OSP) is a traditional treatment for BPH.
• Robot-assisted simple prostatectomy (RASP) is an emerging surgical technique for BPH.

Purpose of the Study:

• To compare the perioperative outcomes of robot-assisted simple prostatectomy (RASP) versus open simple prostatectomy (OSP).
• To evaluate complications and risk factors associated with both surgical approaches for BPH.

Main Methods:

• Retrospective study of 103 patients undergoing simple prostatectomy between 2017-2020.
• Comparison of transvesical OSP with transvesical extraperitoneal RASP using DaVinci Xi robot.
• Analysis of perioperative and postoperative data, including complications and functional outcomes.

Main Results:

• RASP group (47 patients) showed significantly less blood loss (200 vs. 400 mL), shorter hospital stay (5 vs. 10 days), and reduced catheterization time (4 vs. 9 days) compared to OSP (56 patients).
• RASP was associated with fewer grade ≥2 complications (4.3% vs. 23.2%) and reduced need for transfusions (0% vs. 11%).
• Preoperative prostate volume was a risk factor for complications, while RASP was a protective factor.

Conclusions:

• RASP is a safe and effective alternative to OSP for treating BPH.
• RASP demonstrates decreased morbidity, shorter hospital stays, and reduced catheterization times.
• Functional outcomes at 12 months were comparable between RASP and OSP.